IMS MAXIMS to Showcase Proven Dementia Software at Major Clinical Conference

IMS MAXIMSIMS MAXIMS will be demonstrating the benefits of their portfolio of user-focused solutions, including innovative dementia software, to a major clinical audience at the Acute and General Medicine conference in London, 27 - 28th November.

Delegates to the conference, which is expected to attract thousands of senior consultants over the two days, will have the opportunity to speak to representatives of IMS MAXIMS about how they create products and services that are easily adapted to suit each customer.

Furthermore, IMS MAXIMS representatives will be on stand F24 to talk about the organisation's strong track record of involving healthcare professionals at every stage of the development process, ensuring their needs and those of patients are given the highest priority.

This approach was clearly evident, as IMS MAXIMS customer Royal Cornwall Hospitals NHS Trust became one of the first in the country to exceed all its Commissioning Quality for Innovation (CQUIN) targets for dementia care. Using IMS MAXIMS' dementia software, developed based on The Department of Health's CQUIN requirements, the trust is now able to more effectively identify patients with dementia and other causes of cognitive impairment to enable a better referral process, reduced length of stays in hospital and effective follow-up care.

Frazer Underwood, associate director of nursing, Royal Cornwall Hospitals NHS Trust said: "The high profile of our dementia work in Cornwall means that the ability of IMS MAXIMS to contribute meaningfully to improving services is invaluable. We felt really engaged with IMS MAXIMS throughout the development process; they were driven by patient needs, delivering a system which put clinical requirements first."

In addition, IMS MAXIMS will also demonstrate its Patient Administration System (PAS), Electronic Patient Record (EPR) and Integrated Care Pathway solutions.

The MAXIMS PAS currently supports more than 11 million patient records in England and a further two million records in Ireland. The system allows healthcare professionals to replace paper-based systems with electronic records that are fast, efficient and accurate, helping both clinical and admin staff work more efficiently while improving patient safety.

The EPR enables a single, complete electronic patient record to be created that contains all relevant information about every aspect of the patient's care - historic notes, all correspondence, past and future appointments and care detail. Whilst the IMS MAXIMS Integrated Care Pathways allows clinicians to easily co-ordinate multiple care actions in a patient-centered approach, allowing care to be delivered efficiently and as quickly as possible.

Shane Tickell, CEO, IMS MAXIMS added: "The Acute and General Medicine conference provides us with an excellent platform to highlight our dementia module and other software solutions. We are committed to developing systems that support healthcare professionals to safely deliver the right care to patients at the right time. In this way, not only do we contribute to improving outcomes for patients but we also help healthcare organisations as they strive to address the multiple challenges that the NHS faces."

IMS MAXIMS will be exhibiting on stand F24; delegates are invited to come along to find out more about the company's current range of clinical healthcare information solutions.

About the Acute and General Medicine conference
Now in its second year the Acute and General Medicine conference (AGM) is expected to be attended by over 4,000 hospital doctors and NHS managers. The AGM programme allows doctors to follow their learning needs across the medical specialties with pacey, interactive seminars, uniquely offering knowledge and skills training in acute and general medicine.

About IMS MAXIMS
IMS MAXIMS is an electronic patient record provider working towards better, safer patient care. Specialists in developing clinical and administrative software solutions for healthcare providers, IMS MAXIMS currently supports more than 150 organisations, 11 million patient records in the UK, and 1.9 million patient records in Ireland, approx 50% of the population, as well as 20,000 users of IMS MAXIMS products.

IMS MAXIMS is at the heart of the clinical and administrative life of everything from large UK and Irish hospitals, to small specialist independent clinics. It gives patient data to clinicians in exactly the format they need, and allows it to be shared with colleagues and updated in real-time. MAXIMS suits any clinical specialism and is excellent for order communications and reporting. Medical and administrative records can be kept fully up to date, with minimum effort. MAXIMS is web-based so there is no need to install software on computers or invest in expensive extra hardware.

Most Popular Now

European Artificial Intelligence Act Com…

The European Artificial Intelligence Act (AI Act), the world's first comprehensive regulation on artificial intelligence, enters into force. The AI Act is designed to ensure that AI developed and used...

Patient Safety must be Central to the De…

An EPR system brings together different patient information in one place, making it easier to access for healthcare professionals. This information can include patients' own notes, test results, observations by...

ChatGPT Shows Promise in Answering Patie…

The groundbreaking ChatGPT chatbot shows potential as a time-saving tool for responding to patient questions sent to the urologist's office, suggests a study in the September issue of Urology Practice®...

Survey: Most Americans Comfortable with …

Artificial intelligence (AI) is all around us - from smart home devices to entertainment and social media algorithms. But is AI okay in healthcare? A new national survey commissioned by...

AI Spots Cancer and Viral Infections at …

Researchers at the Centre for Genomic Regulation (CRG), the University of the Basque Country (UPV/EHU), Donostia International Physics Center (DIPC) and the Fundación Biofisica Bizkaia (FBB, located in Biofisika Institute)...

Video Gaming Improves Mental Well-Being

A pioneering study titled "Causal effect of video gaming on mental well-being in Japan 2020-2022," published in Nature Human Behaviour, has conducted the most comprehensive investigation to date on the...

New Diabetes Research Links Blood Glucos…

As part of its ongoing exploration of vocal biomarkers and the role they can play in enhancing health outcomes, Klick Labs published a new study in Scientific Reports - confirming...

Machine learning helps identify rheumato…

A machine-learning tool created by Weill Cornell Medicine and Hospital for Special Surgery (HSS) investigators can help distinguish subtypes of rheumatoid arthritis (RA), which may help scientists find ways to...

New AI Software could Make Diagnosing De…

Although Alzheimer's is the most common cause of dementia - a catchall term for cognitive deficits that impact daily living, like the loss of memory or language - it's not...

A New AI Tool for Cancer

Scientists at Harvard Medical School have designed a versatile, ChatGPT-like AI model capable of performing an array of diagnostic tasks across multiple forms of cancers. The new AI system, described Sept...

Vision-Based ChatGPT Shows Deficits Inte…

Researchers evaluating the performance of ChatGPT-4 Vision found that the model performed well on text-based radiology exam questions but struggled to answer image-related questions accurately. The study's results were published...

Bayer Launches New Healthy-Aging Ecosyst…

Combining a scientifically formulated dietary supplement, a leading-edge wellness companion app, and a saliva-based a biological age test by Chronomics, Bayer is taking a big step in the emerging healthy-aging...